Mallinckrodt Initiates Retrospective Study of the Use of Inhaled Nitric Oxide in COVID-19 Patients
- Tuesday, November 10, 2020, 7:01
- Finance
- Add a comment
DUBLIN, Nov. 10, 2020 /PRNewswire/ — Mallinckrodt plc, a global biopharmaceutical company, today announced initiation of a retrospective chart review study, titled “Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)” to collect real-world data on the use of INOmax® (nitric oxide)…
About the Author
adminasapcorp has written 39710 stories on this site.